82 related articles for article (PubMed ID: 11848525)
1. Immunoscintigraphy with a technetium-99m labelled anti-epithelial growth factor receptor antibody in patients with non-small cell lung cancer.
Schillaci O; Danieli R; Picardi V; Bagni O; Di Loreto M; Scopinaro F
Anticancer Res; 2001; 21(5):3571-4. PubMed ID: 11848525
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
3. Targeting of non-small cell lung cancer using HMFG1-99mTc monoclonal antibodies.
Pavlović S; Jovanović D; Radosavljević G; Kozarević N; Nastić-Mirić D; Rebić R; Bosnjáković V; Epenetos A
Med Pregl; 1993; 46 Suppl 1():26-8. PubMed ID: 8569597
[TBL] [Abstract][Full Text] [Related]
4. Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals.
Sobic-Saranovic D; Pavlovic S; Jovanovic D; Nebojsa K; Todorovic-Tirnanic M; Subotic D; Artiko V; Obradovic V
Hell J Nucl Med; 2008; 11(1):16-20. PubMed ID: 18392221
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-antiepidermal growth factor-receptor antibody in patients with tumors of epithelial origin: part II. Pharmacokinetics and clearances.
Iznaga-Escobar N; Torres Arocha LA; Morales Morales A; Ramos Suzarte M; Rodríguez Mesa N; Pérez Rodríguez R
J Nucl Med; 1998 Nov; 39(11):1918-27. PubMed ID: 9829584
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
8. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.
Friedman S; Sullivan K; Salk D; Nelp WB; Griep RJ; Johnson DH; Blend MJ; Aye R; Suppers V; Abrams PG
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1069-78. PubMed ID: 1962776
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.
Crombet T; Torres O; Neninger E; Catalá M; Rodríguez N; Ramos M; Fernández E; Iznaga N; Pérez R; Lage A
Cancer Biother Radiopharm; 2001 Feb; 16(1):93-102. PubMed ID: 11279803
[TBL] [Abstract][Full Text] [Related]
10. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
13. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
14. In vivo study of a technetium labelled anti-EGFr MoAB.
Scopinaro F; De Vincentis G; Banci M; Schillaci O; Di Loreto M; Danieli R; Ierardi M; De Paola AM; Gianni W; Massa R
Anticancer Res; 1997; 17(3B):1761-5. PubMed ID: 9179231
[TBL] [Abstract][Full Text] [Related]
15. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
Li N; Yu L; Zhang C
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
[TBL] [Abstract][Full Text] [Related]
16. NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.
Rusch V; Macapinlac H; Heelan R; Kramer E; Larson S; McCormack P; Burt M; Martini N; Ginsberg R
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):200-4. PubMed ID: 8393504
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.
Ramos-Suzarte M; Rodríguez N; Oliva JP; Iznaga-Escobar N; Perera A; Morales A; Gonzalez N; Cordero M; Torres L; Pimentel G; Borrón M; González J; Torres O; Rodríguez T; Pérez R
J Nucl Med; 1999 May; 40(5):768-75. PubMed ID: 10319748
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
